Articles

Researchers studying the effects of protein adispsin in type 2 diabetes find it activates a beta-cell protective peptide called C3a.

Five-year study challenges alleged increase in risk for severe muscular injury when combining DPP-4 inhibitors with lipid-lowering agents.

A first-of-its-kind study examines the differing effects of sucrose versus glucose intake on circulating glucagon-like peptide-1 (GLP-1).

Does a 12-week high-intensity interval training (HIIT) program show superior glucose control in type 1 diabetes than other forms of exercise?

Better oral health may be linked to better outcomes in patients with diabetes, but which comes first -- gum disease or diabetes? 

Lowering patients' blood pressure could save their brains. 

An analysis of over three million patients assessed the impact of diabetes on in-hospital mortality after myocardial infarction.

A small pilot study investigates how modest hyperglycemia, not hyperinsulinemia, is better for people with type 1 diabetes during exercise.

Canaglifozin reduced risk of cardiovascular death and hospitalizations due to heart failure by 31%.

Are you doing everything you can to ensure your patient has the best quality of life possible with type 2 diabetes?